| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.6 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |